| Integrative analysis identifies four molecular and clinical subsets in uveal melanoma AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ... Cancer cell 32 (2), 204-220. e15, 2017 | 800 | 2017 |
| Uveal melanoma MJ Jager, CL Shields, CM Cebulla, MH Abdel-Rahman, HE Grossniklaus, ... Nature reviews Disease primers 6 (1), 24, 2020 | 545 | 2020 |
| PRAME as an independent biomarker for metastasis in uveal melanoma MG Field, CL Decatur, S Kurtenbach, G Gezgin, PA Van Der Velden, ... Clinical cancer research 22 (5), 1234-1242, 2016 | 264 | 2016 |
| Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target C All-Ericsson, L Girnita, S Seregard, A Bartolazzi, MJ Jager, O Larsson Investigative ophthalmology & visual science 43 (1), 1-8, 2002 | 264 | 2002 |
| Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS W Zuidervaart, F Van Nieuwpoort, M Stark, R Dijkman, L Packer, ... British journal of cancer 92 (11), 2032-2038, 2005 | 260 | 2005 |
| Detection of M2-macrophages in uveal melanoma and relation with survival IHG Bronkhorst, LV Ly, ES Jordanova, J Vrolijk, M Versluis, GPM Luyten, ... Investigative ophthalmology & visual science 52 (2), 643-650, 2011 | 252 | 2011 |
| Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma H Chen, KS Cho, THK Vu, CH Shen, M Kaur, G Chen, R Mathew, ... Nature communications 9 (1), 3209, 2018 | 231 | 2018 |
| Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system P Kodukula, T Liu, NV Rooijen, MJ Jager, RL Hendricks The Journal of Immunology 162 (5), 2895-2905, 1999 | 230 | 1999 |
| Establishment and characterization of an uveal‐melanoma cell line I De Waard‐Siebinga, DJR Blom, M Griffioen, PI Schrier, ... International journal of cancer 62 (2), 155-161, 1995 | 229 | 1995 |
| Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations X Chen, Q Wu, L Tan, D Porter, MJ Jager, C Emery, BC Bastian Oncogene 33 (39), 4724-4734, 2014 | 219 | 2014 |
| Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide S Walpole, AL Pritchard, CM Cebulla, R Pilarski, M Stautberg, ... JNCI: Journal of the National Cancer Institute 110 (12), 1328-1341, 2018 | 207 | 2018 |
| Uveal melanoma: Towards a molecular understanding KN Smit, MJ Jager, A de Klein, E Kiliҫ Progress in retinal and eye research 75, 100800, 2020 | 182 | 2020 |
| Promoter Hypermethylation: A Common Cause of Reduced p16INK4a Expression in Uveal Melanoma PA van der Velden, JAW Metzelaar-Blok, W Bergman, H Monique, ... Cancer research 61 (13), 5303-5306, 2001 | 173 | 2001 |
| Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma W Maat, LV Ly, ES Jordanova, D de Wolff-Rouendaal, NE Schalij-Delfos, ... Investigative ophthalmology & visual science 49 (2), 505-510, 2008 | 168 | 2008 |
| Neuroinflammation and microglia in glaucoma: time for a paradigm shift X Wei, KS Cho, EF Thee, MJ Jager, DF Chen Journal of neuroscience research 97 (1), 70-76, 2019 | 159 | 2019 |
| Mechanisms of local immunosuppression in cutaneous melanoma ME Polak, NJ Borthwick, FG Gabriel, P Johnson, B Higgins, J Hurren, ... British journal of cancer 96 (12), 1879-1887, 2007 | 153 | 2007 |
| Vascular endothelial growth factor a in eyes with uveal melanoma GSO Missotten, IC Notting, RO Schlingemann, HJ Zijlmans, C Lau, ... Archives of Ophthalmology 124 (10), 1428-1434, 2006 | 153 | 2006 |
| Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma IHG Bronkhorst, THK Vu, ES Jordanova, GPM Luyten, SH van der Burg, ... Investigative ophthalmology & visual science 53 (9), 5370-5378, 2012 | 144 | 2012 |
| HLA expression in uveal melanoma: there is no rule without some exception MJ Jager, HM Hurks, J Levitskaya, R Kiessling Human immunology 63 (6), 444-451, 2002 | 143 | 2002 |
| Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. DJ Blom, GP Luyten, C Mooy, S Kerkvliet, AH Zwinderman, MJ Jager Investigative ophthalmology & visual science 38 (9), 1865-1872, 1997 | 143 | 1997 |
